Document:

EX-10.26

 EXHIBIT 10.26 

AMENDED AND RESTATED 

EMPLOYMENT AGREEMENT 

THIS AMENDED AND RESTATED EMPLOYMENT
AGREEMENT (this “Agreement”) is made by and amongst ECPM Holdings, LLC (together with its subsidiaries and affiliates, the “Company”), having its
principal offices at 11810 Wills Road, Alpharetta, GA 30005 USA, and David N. Gill (the “Executive”), effective as of May 1, 2015. 

WHEREAS, the Company desires to continue to employ the Executive in the position of Chief Financial Officer for the
Company; and 
 WHEREAS, the Executive desires to be employed by the Company as its Chief Financial Officer; 

NOW THEREFORE, in consideration of the premises and the mutual covenants herein contained, the Company
and the Executive hereby agree as follows: 
 1. Definitions. For purposes of this Agreement, the following terms shall have the
meanings set forth below: 
 (a) “Annual Base Salary” shall mean the
Executive’s annual rate of regular base annual compensation prior to any reduction under (i) a salary reduction agreement pursuant to Section 401(k) or Section 125 of the Code or (ii) any plan or arrangement deferring any
base salary. 
 (b) “Board” shall mean the Board of Directors of the
Company. The Board may delegate its authority to a committee of the Board (the “Committee”), including without limitation a compensation committee, which shall consist of outside directors as defined under Section 162(m)
the Code, and related Treasury regulations, and “non-employee directors” as defined under Rule 16b-3 under the Securities Exchange Act of 1934 (the “Exchange Act”). Unless otherwise specified in the Agreement, the
term “Board” shall include any Committee (or sub-committee) to which the Board’s authority has been delegated. 

(c) “Cause” any of the following (i) conviction of the Executive by a court of
competent jurisdiction of any felony or a crime involving dishonesty; (ii) the Executive’s grossly negligent or willful and material breach of the Executive’s duties and responsibilities; (iii) the Executive’s willful and
material misconduct in the performance of Executive’s duties; (iv) the Executive’s failure to comply with any lawful instruction or directive of the Board or; (v) the Executive’s willful and material breach of the Employment
Covenants Agreement. An event described in (ii)—(v) above shall not be treated as “Cause” until after the Executive has been given written notice of such event, failure or conduct and the Executive fails to cure such event,
failure, conduct or breach, if curable, within thirty (30) days from such written notice. In any event, the Executive shall not be deemed to have been terminated for Cause unless the Company shall have given a reasonable opportunity to
Executive to appear before the Board to request reconsideration. Failure of the Company to meet financial or performance targets or goals shall not be deemed to be a breach pursuant to subsections (ii), (iii) or (iv) above. 

  
 1 

 (d) “Change in Control” shall mean the occurrence of one
(1) or more of the following events: 
 (i) The date that any Person (other than a trustee or other fiduciary holding securities
under an employee benefit plan of the Company, or a company owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company), or more than one such Person acting as a
group (as determined under Treasury Regulations Section 1.409A-3(i)(5)(v)(B)), acquires ownership of the stock of the Company representing more than thirty-five percent (35%) of the total combined voting power of the Company’s
then-outstanding stock; 
 (ii) The date that any Person (other than a trustee or other fiduciary holding securities under an
employee benefit plan of the Company, or a company owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company), or more than one such Person acting as a group (as
determined under Treasury Regulations Section 1.409A-3(i)(5)(v)(B)), acquires assets from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of the
Company immediately before such acquisition (with “gross fair market value” determined without regard to any liabilities associated with such assets); or 

(iii) The date that the majority of members of the Board are replaced during any twelve (12)-month period by directors whose
appointment or election is not endorsed by a majority of the members of the Board prior to the date of such appointment or election. 

Notwithstanding the foregoing, in no event shall a Change in Control be deemed to have occurred if, with respect to the Executive, the
Executive is part of a purchasing group which consummates the Change in Control transaction. The Executive shall be deemed “part of the purchasing group” for purposes of the preceding sentence if the Executive is an equity participant or
has agreed to become an equity participant in the purchasing company or group (except for (a) passive ownership of less than five percent (5%) of the voting securities of the purchasing company; or (b) ownership of equity
participation in the purchasing company or group which is not more than ten percent (10%), as determined prior to the Change in Control by a majority of the non-employee continuing directors of the Board). 

Notwithstanding any provision herein to the contrary, the Company’s initial public offering shall not be a Change in Control for purposes
of this Agreement. 
 (e) “COBRA” shall mean the Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended, as well as any applicable state law of similar effect 
 (f)
“Code” shall mean the Internal Revenue Code of 1986, as amended, and, as applicable, Treasury Regulations promulgated thereunder. 

(g) “Company” shall mean EndoChoice Holdings, Inc. and any successor to its business and/or assets which assumes
(either expressly, by operation of law or otherwise) and/or agrees to perform this Agreement by operation of law or otherwise (except in determining, under subsection (d) hereof, whether or not any Change in Control of the Company has occurred
in connection with such succession). 

  
 2 

 (h) “Date of Termination” shall mean
with respect to any purported termination of the Executive’s employment, the effective date of the Executive’s Separation from Service. 

(i) “Disability” shall mean the Executive’s inability for medical reasons to
perform the essential duties of the Executive’s position for either ninety (90) consecutive calendar days or one hundred twenty (120) business days in a twelve (12) month period by reason of any medically determined physical or
mental impairment as determined by a medical doctor selected by written agreement of the Company and the Executive upon the request of either party by notice to the other. 

(j) “Employment Covenants Agreement” shall mean the Employment Covenants Agreement
between the Executive and the Company dated August 15, 2014.  
 (k) “Good
Reason” shall mean (i) a material change in the character or scope of the Executive’s position, duties, Annual Base Salary, responsibilities, reporting or authority, including without limitation any requirement that the
Executive report to a Person other than the Chief Executive Officer; (ii) any material reduction in the Executive’s Target Bonus opportunity; (iii) the Company requires Executive to change the Executive’s principal location of
work to a location that is greater than fifty (50) miles from the location thereof as of the effective date of this Agreement without the Executive’s written consent; (iv) failure of the Company to have any successor entity assume and
perform this Agreement pursuant to Section 7(d); or (v) the material breach of this Agreement by the Company or any successor thereto. A condition described in (i) – (v) above shall not be treated as “Good Reason”
until after the Executive has given written notice to the Company of the existence of the condition not less than thirty (30) days after the initial existence of the condition and the Company fails to cure such condition within thirty
(30) days from such written notice.  
 (l) “Person” shall have
the meaning ascribed thereto in Section 3(a)(9) of the Exchange Act, as modified, applied and used in Sections 13(d) and 14(d) thereof; provided, however, a Person shall not include (i) the Company or any of its respective
subsidiaries, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its respective subsidiaries (in its capacity as such), or (iii) an underwriter temporarily holding securities
pursuant to an offering of such securities. 
 (m) “Release” shall mean a general mutual release of the
Company and the Executive containing a mutual non-disparagement clause in substantially the form attached hereto as Exhibit A. The Release must be signed by the Executive and become irrevocable and effective in accordance with its terms not
later than sixty (60) days following the Date of Termination, unless a longer period for execution and effectiveness is expressly required by applicable law. 

(n) “Separation from Service” shall mean the date after which (i) no further
services are reasonably expected to be performed by the Executive or (ii) the level of bona fide  

  
 3 

 
services that the Executive would perform (whether as an employee or as an independent contractor) would permanently decrease to no more than 20% of the average level of bona fide services
performed (whether as an employee or as an independent contractor) over the preceding 36-month period. The determination of such date shall be made in good faith by the Board based on the applicable facts and circumstances and in accordance with the
requirements of Treasury Regulation Section 1.409A-1(h). 
 (o) “Severance Commencement
Date” shall mean the date on or following the Date of Termination and on which the Release becomes effective and irrevocable in accordance with its terms; provided, however, that if the Date of Termination occurs within sixty
(60) days prior to the end of a calendar year, the Severance Commencement Date will be the later of (i) the date on which the Release becomes effective and irrevocable in accordance with its terms, or (ii) the first day of the
calendar year immediately following the Date of Termination. 
 2. Term of this Agreement. The term of this Agreement,
as amended, shall commence upon the date of this Agreement set forth above and shall continue until terminated in accordance with Section 4 (the “Term”). 

3. Duties; Scope of Employment; Compensation and Benefits. 

(a) Position and Duties. The Company shall employ the Executive in the position of Chief Financial Officer of the Company, reporting to
the Chief Executive Officer. During the Term, the Executive will devote substantially all of the Executive’s business efforts and time to the Company. The Executive agrees not to actively engage in any other employment, occupation or consulting
activity for any direct or indirect remuneration without the prior approval of the Board, provided, however, that the Executive may engage in the following as long as such activities do not materially interfere with the Executive’s duties and
responsibilities with the Company: (i) serve on the board of two (2) unaffiliated corporations; (ii) serve on the boards of trade associations or charitable organizations or otherwise engage in charitable activities and community
affairs; or (iii) manage the Executive’s personal investments and affairs; provided, however, that Executive may serve on the Board of more than two (2) unaffiliated corporations subject to the reasonable prior approval of the Board,
which shall not be unreasonably withheld or delayed. 
 (b) Annual Base Salary. The Executive’s Annual Base Salary shall
equal Three Hundred Twenty Five Thousand Dollars ($325,000). The Annual Base Salary amount shall be reviewed not less frequently than annually by the Board and, in the sole discretion of the Board, may be adjusted upward. Notwithstanding the
preceding sentence, the Executive’s annual salary may be reduced if such reduction is pro rata among substantially all of the Company’s senior level executives as a group. 

(c) Bonus. The Executive’s target bonus opportunity shall be forty-five percent (45%) of the
Executive’s Annual Base Salary (the “Target Bonus”). This target percentage shall be reviewed not less frequently than annually by the Board and, in its sole discretion, may be adjusted
upward. The Executive’s actual bonus earned shall be determined based on the Executive’s performance and achievement of target objectives and such other terms agreed to in good faith by the Company and the Executive. 

  
 4 

 (d) Pension and Welfare Plans. During the Term, the Executive and the Executive’s
dependents, if applicable, shall be entitled to participate in all incentive, savings and retirement plans, health and welfare benefit plans, practices, policies and programs (including, without limitation, medical, prescription, dental, disability,
employee life, group life, accidental death and travel accident insurance plans and programs) sponsored by the Company or its affiliates on the same terms and conditions generally applicable to executives of the Company; provided, however, the
Executive shall not be eligible to participate in the EndoChoice Holdings, Inc. Officer Severance Benefit Plan or any other severance arrangement that may be maintained by the Company from time to time (other than the severance provided in this
Agreement) unless such arrangement specifically designates Executive as eligible to participate therein. 
 (e) Equity Plans.
The Executive shall be entitled to participate in any stock option, restricted stock, stock appreciation rights, or any other equity compensation plan or program sponsored by the Company or its affiliates on the same terms and conditions
generally applicable to executives of the Company. Notwithstanding the foregoing, except as expressly otherwise provided herein, the Executive shall not have a guaranteed right to awards under such plans at any time or in any particular amount. Any
equity interests or rights to purchase equity interests in the Company held by the Executive and issued pursuant to the EndoChoice Holdings, Inc. 2015 Omnibus Equity Incentive Plan or any successor plan (the “Equity
Plan”) shall be administered and subject to the terms of the Equity Plan and any amendments thereto, including, without limitation, the Equity Plan’s provisions relevant to a Change in Control. 

(f) Fringe Benefits and Prerequisites. The Executive shall be entitled to fringe benefits and prerequisites available to executives in
accordance with the plans, practices, programs and policies of the Company from time to time. 
 (g) Expenses. The Executive
shall be entitled to receive prompt reimbursement for all reasonable business expenses incurred by the Executive in accordance with the applicable policy of the Company and its affiliated companies as in effect from time to time. 

(h) Paid Time Off. The Executive shall be entitled to four (4) weeks of paid time off in accordance with the general policy of the
Company applicable to executives as in effect from time to time. 
 (i) Indemnification/D&O Coverage/Other Benefits. The
Executive shall be a party to any indemnification or similar agreement into which the Company and any other senior executives enter, on terms no less favorable than any such other senior executives. The Executive will also be indemnified to the
fullest extent permitted by law, from and against any and all liability, loss, damages or expenses incurred as a result of, arising out of, or in any way related to, Executive’s lawful service as an employee, officer, director or agent of the
Company or a Company affiliate, in accordance with the Company’s Certificate of Incorporation and bylaws. The Company shall maintain a directors and officers liability insurance policy (including commercially reasonable tail coverage) covering
the Executive in his capacity as an officer and director of the Company and any Company affiliate. The Company’s obligation to indemnify the Executive shall survive termination of this Agreement. The Executive shall be entitled to prompt
reimbursement of the full cost of one annual executive physical examination, to the extent not covered by the Company’s group health plan and in accordance with the requirements of Treasury Regulation Section 1.105-11(g).

  
 5 

 4. Termination. The Term and Executive’s employment shall terminate upon the
occurrence of any of the following events: 
 (a) Termination Without Cause; Resignation for Good Reason; Death; Disability.

 (i) General. The Company may remove the Executive at any time without Cause from the position in which the
Executive is employed hereunder upon not less than thirty (30) days’ prior written notice of termination to the Executive; provided, however, that, in the event that such notice is given, the Executive shall be allowed reasonable
time away from the office to seek other employment. In addition, the Executive may initiate termination of employment by resigning under this Section 4(a) for Good Reason. The Executive shall give the Company not less than thirty
(30) days’ prior written notice of termination of such resignation for Good Reason.  
 (ii) Death, Disability, or Not
in Connection with a Change in Control. Upon any removal without Cause or resignation for Good Reason described in Section 4(a)(i) above (other than such a removal or resignation that occurs during the period commencing on the date the
Company enters into a written agreement which, if consummated, would and does result in a Change in Control and ending twenty-four (24) months following the effective date of a Change in Control) or in the event of Executive’s death or
termination of employment as a result of Disability, the Executive shall be entitled to receive, subject to the effectiveness and irrevocability of the Release, cash severance equal to: (a) the sum of (A) fifty percent (50%) the
Executive’s Annual Base Salary at the rate in effect immediately prior to the Date of Termination, plus (B) fifty percent (50%) of the Executive’s Target Bonus (the “Severance Bonus”); (b) a pro-rated
bonus for the year in which the Date of Termination occurs, calculated as the product of (i) the full annual target bonus for the year in which the Date of Termination occurs and (ii) a fraction, the numerator of which is the number of
days during which the Executive was employed by the Company in the year in which the Date of Termination occurs, and the denominator of which is three hundred sixty five (365) (the “Pro-Rated Bonus”); and (c) if
Executive timely elects continuation health care coverage pursuant to COBRA for himself and/or his eligible dependents, the Company shall pay the applicable COBRA premiums for such coverage for up to eighteen (18) months, or such earlier time
as the Executive (i) ceases to be eligible for such continuation coverage for any reason, or (ii) becomes eligible for coverage under another employer’s group health plan, regardless of whether such coverage is actually elected. In
addition, Executive’s equity awards will accelerate vesting in full and shall remain exercisable until the earlier of twenty four (24) months or the expiration of their original term (as determined without regard to the Executive’s
termination of employment). For purposes of determining the number of shares that will vest pursuant to the foregoing provision with respect to any performance based vesting equity award that has multiple vesting levels depending upon the level of
performance, vesting acceleration shall occur with respect to the number of shares subject to the equity award as if the applicable performance criteria had been attained at a 100% level. Subject to any delay in payment required by
Section 4(c), the Company will pay (a) the Cash Severance, less the Severance Bonus and Pro-Rated Bonus in substantially 

  
 6 

 
equal installments on the Company’s regular payroll schedule and subject to standard deductions and withholdings over the six (6) month period immediately following the Date of
Termination, and (b) the Severance Bonus and Pro-Rated Bonus in a lump sum on the date that the Company would otherwise pay the annual bonus for that year to other executives whose employment has not terminated (but in no event later than
March 15 of the year following the year in which the annual bonus would have otherwise been earned). However, no payments of the Cash Severance will be made prior to the Severance Commencement Date. On the first payroll pay day following the
Severance Commencement Date, the Company will pay the Executive in a lump sum the Cash Severance the Executive would otherwise have received on or prior to such date but for the delay in payment related to the effectiveness and irrevocability of the
Release, with the balance of the Cash Severance being paid as originally scheduled. 
 (iii) In Connection with a Change in Control.
 
 (1) Severance. Upon any removal without Cause or resignation for Good Reason described in
Section 4(a)(i) above that occurs during the period commencing on the date the Company enters into a written agreement which, if consummated, would and does result in a Change in Control and ending twenty four (24) months following the
effective date of a Change in Control (a “Qualifying CIC Termination”) (1) the Executive shall be entitled to receive, subject to the effectiveness and irrevocability of the Release, cash severance equal to the sum of
(a) one hundred percent (100%) of the Executive’s Annual Base Salary at the rate in effect immediately prior to the Date of Termination (the “CIC Severance”), and (b) the Executive’s full annual
target bonus for the year in which the Date of Termination occurs (the “CIC Severance Bonus”) and (c) a pro-rated bonus for the year in which the Date of Termination occurs, calculated as the product of (i) the full
annual bonus for the year in which the Date of Termination occurs and (ii) a fraction, the numerator of which is the number of days during which the Executive was employed by the Company in the year in which the Date of Termination occurs, and
the denominator of which is three hundred and sixty five (365) (the “Pro-Rated CIC Bonus”). Subject to any delay in payment required by Section 4(c), the Company will pay (a) the CIC Severance, less the CIC
Severance Bonus and the Pro-Rated CIC Bonus, in a lump sum on the Severance Commencement Date, and (b) the CIC Severance Bonus in a lump sum on the date that the Company would otherwise pay the annual bonus for that year to other executives
whose employment has not terminated (but in no event later than March 15 of the year following the year in which the annual bonus would have otherwise been earned).  

(2) Equity. If the Executive’s employment terminates due to a Qualifying CIC Termination, then subject to the Executive’s
timely provision of an effective and irrevocable Release, and effective as of the later of the Severance Commencement Date or the effective date of the Change in Control, the Executive’s equity awards will accelerate vesting in full and shall
remain exercisable until the earlier of twenty four (24) months or the expiration of their original term (as determined without regard to the Executive’s termination of employment); provided, however, that in order to give effect to the
intent of the foregoing provision, to the extent the Severance Commencement Date is later than the effective date of a Change in Control where the Executive’s equity award is not assumed, substituted or continued by the acquiring or surviving
entity, the vesting of the Executive’s equity awards will be contingent upon the Executive’s timely provision of an effective and irrevocable Release, but will be deemed to have been effective immediately prior to the Change in Control.
For purposes of determining the  

  
 7 

 
number of shares that will vest pursuant to the foregoing provision with respect to any performance based vesting equity award that has multiple vesting levels depending upon the level of
performance, vesting acceleration shall occur with respect to the number of shares subject to the equity award as if the applicable performance criteria had been attained at the greater of a 100% level or the level of actual performance as of the
date of the Change in Control. 
 (3) COBRA Coverage. If the Executive’s employment terminates due to a Qualifying CIC
Termination, then subject to the Executive’s timely provision of an effective and irrevocable Release, if Executive timely elects continuation health care coverage pursuant to COBRA for himself and/or his eligible dependents, the Company shall
pay the applicable COBRA premiums for such coverage for up to eighteen (18) months, or such earlier time as the Executive (i) ceases to be eligible for such continuation coverage for any reason, or (ii) becomes eligible for coverage
under another employer’s group health plan, regardless of whether such coverage is actually elected. 
 (b) Termination for
Cause; Voluntary Resignation Without Good Reason. In the event that the Executive voluntarily terminates his employment for any reason other than Good Reason or in the event that Company terminates the Executive for Cause no further payments
shall be due under this Agreement, except that the Executive shall be entitled to any amounts earned, accrued or owing but not yet paid under Section 3 above and any benefits accrued or earned under the Company’s benefit plans and programs
or to which Executive is otherwise entitled under applicable law. 
 (c) Compliance with Section 409A of the Code. 

(i) All payments and benefits provided under the Agreement are intended to satisfy the requirements for an exemption from application
of Section 409A of the Code to the maximum extent that an exemption is available and any ambiguities herein shall be interpreted accordingly. Notwithstanding anything to the contrary set forth herein, any payments and benefits provided under
the Agreement that constitute “deferred compensation” within the meaning of Section 409A of the Code and the regulations and other guidance thereunder shall not commence in connection with the Executive’s termination of
employment unless and until the Executive has also incurred a “separation from service,” as such term is defined in Treasury Regulations Section 1.409A-1(h). 

(ii) It is intended that each installment of the payments provided for in this Section 4 is a separate “payment” for
purposes of Treasury Regulations Section 1.409A2(b)(2)(i). For the avoidance of doubt, it is intended that payments of the amounts set forth in this Section 4 satisfy, to the greatest extent possible, the exemptions from the application of
Section 409A provided under Treasury Regulation 1.409A-1(b)(4) and 1.409A-1(b)(9)(v). 
 (iii) Any provision of this
Agreement to the contrary notwithstanding if at the time of the Executive’s Date of Termination Executive is a “specified employee,” within the meaning of Section 409A of the Code, then to the extent any payment or benefit that
the Executive becomes entitled to under this Agreement on account of his Separation from Service would be considered nonqualified deferred compensation under Section 409A of the Code, such 

  
 8 

 
payment or benefit shall be paid or provided at the date which is the earlier of (i) six (6) months and one day after the Date of Termination and (ii) the date of the
Executive’s death (the ‘Delay Period”). Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section 4(d) (whether they would have otherwise
been payable in a single sum or in installments in the absence of such delay) shall be paid or provided to the Executive in a lump-sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the
normal payment dates specified for them herein. 
 (iv) Any reimbursements provided under this Agreement that
constitute deferred compensation within the meaning of Section 409A of the Code shall be made or provided in accordance with the requirements of Section 409A of the Code, including, without limitation, that (i) in no event shall any
fees, expenses or other amounts eligible to be reimbursed by the Company under this Agreement be paid later than the last day of the calendar year next following the calendar year in which the applicable fees, expenses or other amounts were
incurred; (ii) the amount of expenses eligible for reimbursement in any given calendar year shall not affect the expenses that the Company is obligated to reimburse in any other calendar year, provided that the foregoing clause (ii) shall
not be violated with regard to expenses reimbursed under any arrangement covered by Code Section 105(b) solely because such expenses are subject to a limit related to the period the arrangement is in effect; (iii) the Executive’s
right to have the Company pay or provide such reimbursements may not be liquidated or exchanged for any other benefit; and (iv) in no event shall the Company’s obligations to make such reimbursements apply later than the Executive’s
remaining lifetime. 
 5. Non-Disclosure; Proprietary Information and Inventions, etc. The Executive agrees to continue to be bound
and abide by the Employment Covenants Agreement. Executive also acknowledges that nothing in this Agreement relieves the Executive of his obligations under the Employment Covenants Agreement. 

6. Limitation on Payments; Section 280G. In the event the severance and other benefits provided for in this Agreement or otherwise
payable to Executive (i) are “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section 6, would be subject to the “golden parachute” excise tax imposed by
Section 4999 of the Code, then Executive’s severance benefits will be either: 
  

	 	(a)	delivered in full, or 

  

	 	(b)	delivered as to such lesser extent which would result in no portion of such severance benefits being subject to the excise tax under Section 4999 of the Code, 

whichever of (a) or (b), taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999 of the
Code, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance benefits. If a reduction in the severance and other benefits constituting “parachute payments” is necessary so that no portion of such
severance benefits is subject to excise tax under Section 4999 of the Code, the reduction shall be made in accordance with Section 409A of the Code and occur in the following order: (1) payments which do not constitute nonqualified
deferred compensation subject to Section 409A 

  
 9 

 
of the Code; (2) reduction of the cash severance payments; (3) cancellation of accelerated vesting of equity awards; and (4) reduction of continued employee benefits. In the event
that acceleration of vesting of equity award compensation is to be reduced, such acceleration of vesting shall be cancelled in the reverse order of the date of grant of Executive’s equity awards. Unless the Company and Executive otherwise agree
in writing, any determination required under this Section 6 will be made by the Company’s independent accounting firm, whose determination will be conclusive and binding upon Executive and the Company for all purposes. 

7. Miscellaneous. 
 (a)
Legal Costs. The Company shall reimburse the Executive for reasonable legal fees and expenses incurred if the Executive prevails on any issue which is the subject of such of a lawsuit or arbitration brought by the Executive or the Company as a
result of any dispute with any party (including, but not limited to, the Company and/or any affiliate of the Company) regarding the provisions of this Agreement. Otherwise, the Executive and the Company shall be responsible for its own legal fees
and expenses in connection with such action. The Company will reimburse the Executive for reasonable legal fees and expenses directly relating to the negotiation of this Agreement up to a maximum of Ten Thousand Dollars ($10,000).  

(b) Arbitration. In the event of any dispute under the provisions of this Agreement, other than a dispute in which the primary relief
sought is an equitable remedy such as an injunction, the parties shall be required to have the dispute, controversy or claim settled by arbitration in Atlanta, Georgia in accordance with the National Rules for the Resolution of Employment Disputes
then in effect of the American Arbitration Association, before one arbitrator. Any award entered by the arbitrator shall be final, binding and nonappealable and judgment may be entered thereon by either party in accordance with applicable law in any
court of competent jurisdiction. This arbitration provision shall be specifically enforceable. The arbitrator shall have no authority to modify any provision of this Agreement or to award a remedy for a dispute involving this Agreement other than a
benefit specifically provided under or by virtue of the Agreement. 
 (c) No Mitigation. The Company agrees that, if the
Executive’s employment is terminated during the Term, the Executive is not required to seek other employment or to attempt in any way to reduce any amounts payable to the Executive by the Company pursuant to this Agreement. Further, the amount
of any payment or benefit provided for in Section 4 of this Agreement shall not be reduced by any compensation earned by the Executive as the result of employment by another employer, by retirement benefits, or offset against any amount claimed
to be owed by the Executive to the Company or any of their respective subsidiaries. However, the severance benefits provided under this Agreement are intended to satisfy, to the greatest extent possible, any and all statutory obligations that may
arise out of the Executive’s termination of employment including, without limitation, the Worker Adjustment and Retraining Notification Act. 

(d) Successors. In addition to any obligations imposed by law upon any successor to the Company, the Company will require any successor
(whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession had taken place. 

  
 10 

 (e) Binding Agreement. This Agreement shall inure to the benefit of and be enforceable by
the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Executive shall die while any amount would still be payable to the Executive hereunder (other than
amounts which, by their terms, terminate upon the death of the Executive) if the Executive had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the executors,
personal representatives or administrators of the Executive’s estate. 
 (f) Notices. For the purpose of this Agreement,
notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States certified mail, return receipt requested, postage prepaid, addressed to the
respective addresses set forth below, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon actual receipt: 

To the Company: 
 EndoChoice

 11810 Wills Road 

Alpharetta, GA 30005 

Attention: CEO 
 Facsimile:
770-962-6981 
 With copy to: 

Keith Townsend 
 King &
Spalding LLP 
 1180 Peachtree Street N.E. 

Atlanta, GA 30309 
 Facsimile:
404-572-5100 
 To the Executive: 

Mr. David Gill 
 At the
address most recently on file with the Company 
 With copy to: 

Joseph M. Yaffe 
 Skadden, Arps,
Slate, Meagher & Flom LLP 
 525 University Avenue, Suite 1400 

Palo Alto, California 94301 

Facsimile: 650-798-6552 

  
 11 

 (g) Amendments. No provision of this Agreement may be modified, waived or discharged
unless such waiver, modification or discharge is agreed to in writing and signed by the Executive and such officer as may be specifically designated by the Company. No waiver by either party hereto at any time of any breach by the other party hereto
of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. 

(h) Entire Agreement. Except as otherwise provided, this Agreement contains the entire agreement between the parties concerning the
subject matter hereof and supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, express or implied, between the parties with respect thereto. 

(i) Applicable Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the
State of Georgia without regard to the principles of conflict of laws thereof. 
 (j) Captions. The captions of this Agreement
are not part of the provisions hereof and shall have no force or effect. 
 (k) Withholding. Any payments provided for
hereunder shall be paid net of any applicable withholding required under federal, state or local law and any additional withholding to which the Executive has agreed. 

(l) Survivorship. The rights and obligations of the Company and the Executive under this Agreement shall survive the expiration of the
Term. 
 (m) Mutual Intent. All parties participated in the drafting of the Agreement, and the language used in this Agreement
is the language chosen by the Executive and the Company to express their mutual intent . The parties agree that in the event that any language, section, clause, phrase or word used in the Agreement is determined to be ambiguous, no presumption shall
arise against or in favor of either party and that no rule of strict construction shall be applied against either party with respect to such ambiguity. 

(n) Validity. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of
any other provision of this Agreement, which shall remain in full force and effect. 
 (o) Counterparts. This Agreement may be
executed in several counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 

[Signature Page Follows] 

  
 12 

 IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the date first written above. 
  

			
	ECPM HOLDINGS, LLC
		
	By:		/s/ Scott Huennekens
			Scott Huennekens
			Chairman of the Board
	
	EXECUTIVE
	
	 /s/ David N. Gill

David N. Gill

  
 13 

 EXHIBIT A 

MUTUAL RELEASE OF CLAIMS 

(To be signed on or within 21 days after the employment termination date.) 

Pursuant to the terms of the Amended and Restated Employment Agreement (the “Agreement”) by and amongst ECPM HOLDINGS,
LLC (the “Company”), and David Gill (the “Executive”) effective as of                     , the Company and the
Executive hereby enter into the following Mutual Release of Claims (the “Release”): 
 1. Executive’s Release of Claims:

 Executive understands that, on the last date of his employment with the Company, the Company will pay him any accrued salary and
accrued and unused vacation to which he is entitled by law, regardless of whether he signs this Release, but he is not entitled to the severance benefits provided in the Agreement unless he signs and returns this Release to the Company and allows it
to become effective. 
 In exchange for payment of benefits set forth in Section 4 of the Agreement, Executive hereby generally and
completely releases the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns (collectively the “Released
Parties”) of and from any and all claims, liabilities and obligations, both known and unknown, arising out of or in any way related to events, acts, conduct, or omissions occurring at any time prior to or at the time that Executive
signs this Release (the “Executive Released Claims”). This general release includes, but is not limited to: (1) all claims arising out of or in any way related to Executive’s employment with the Company or the
termination of that employment; (2) all claims related to Executive’s compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock
options, or any other ownership or equity interests in the Company; (3) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing (including claims based on or arising under the
Agreement); (4) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all federal, state, and local statutory claims, including claims for discrimination,
harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act (as amended)
(“ADEA”), and the federal Family and Medical Leave Act. 
 Executive understands that notwithstanding the foregoing,
the following are not included in the Executive Released Claims (the “Executive Excluded Claims”): (i) any rights or claims for indemnification Executive may have pursuant to any written indemnification agreement to
which he is a party, the charter, bylaws, or operating agreements of any of the Released Parties, or under applicable law; (ii) any rights or claims pursuant to any directors and officers liability insurance policy of which Executive is a
direct or indirect beneficiary; (iii) any rights or claims to compensation or benefits to which Executive has a vested or non-forfeitable right as of 

  
 14 

 
his termination of employment with the Company; (iii) any rights or claims to enforce any provisions of the Agreement or (iv) any rights which cannot be waived as a matter of law. In
addition, Executive understands that nothing in this Release prevents him from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission or the Department of Labor, except that Executive
acknowledges and agrees that he shall not recover any monetary benefits in connection with any such claim, charge or proceeding with regard to any claim released herein. Executive hereby represents and warrants that, other than the Executive
Excluded Claims, Executive is not aware of any claims he has or might have against any of the Released Parties that are not included in the Executive Released Claims. 

Executive acknowledges that he is knowingly and voluntarily waiving and releasing any rights he may have under the ADEA, and that the
consideration given for the waiver and release in the preceding paragraph is in addition to anything of value to which he is already entitled. Executive further acknowledges that he has been advised by this writing that: (1) his waiver and
release do not apply to any rights or claims that may arise after the date he signs this Release; (2) he should consult with an attorney prior to signing this Release (although he may choose voluntarily not to do so); (3) he has twenty-one
(21) days to consider this Release (although he may choose voluntarily to sign it earlier); (4) he has seven (7) days following the date he signs this Release to revoke it by providing written notice of revocation to the Chairman of
the Company’s Board of Directors; and (5) this Release will not be effective until the date upon which the revocation period has expired, which will be the eighth calendar day after the date Executive signs it provided that he does not
revoke it and that the Company has signed this Release by such date (the “Effective Date “). 
 Executive hereby
represents that he has been paid all compensation owed and for all hours worked, he has received all the leave and leave benefits and protections for which he is eligible, pursuant to the Family and Medical Leave Act or otherwise, and he has not
suffered any on-the-job injury for which he has not already filed a workers’ compensation claim. 
 2. Company’s Release of Claims: 

The Company hereby generally and completely releases Executive of and from any and all claims, liabilities, and obligations, both known and
unknown, arising out of or in any way related to events, acts, conduct or omissions occurring at any time prior to or at the time the Company signs this Release (the “Company Released Claims”); provided, however, that
this Release shall not extend to: (1) any claims that may arise out of any events, acts, conduct or omissions occurring after this Release is executed, including without limitation, any claims for breach of the Agreement; (2) any claims
arising at any time out of Executive’s obligations to protect the Company’s proprietary information, including without limitation, any claims arising from Executive’s obligations under his Information and Inventions Agreement and his
Patent, Copyright and Nondisclosure Agreement, or common law claims arising from these obligations; or (3) any claims arising from any actions by Executive which were intentional or amount to gross negligence during his employment with the
Company which were outside of his authority as Chief Financial Officer or outside of the course and scope of his employment (the “Company Excluded Claims”). 

  
 15 

 The Company hereby represents and warrants that, other than the Company Excluded Claims, it is
not aware of any claims it has or might have against Executive that are not included in the Company Released Claims. 
 3. Additional Agreements:

 The parties hereby further agree as follows: (1) Executive agrees not to disparage the Company, its parent, or its or their
officers, directors, employees, shareholders, affiliates and agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation, and the Company agrees not to, and agrees to instruct its executives,
representatives and members of its Board of Directors not to, disparage Executive in any manner likely to be harmful to his business reputation or personal reputation (although the parties may respond accurately and fully to any question, inquiry or
request for information as required by legal process); (2) not to voluntarily (except in response to legal compulsion) assist any third party in bringing or pursuing any proposed or pending litigation, arbitration, administrative claim or other
formal proceeding against the other party, or against the Released Parties; and (3) to reasonably cooperate with the other party, by voluntarily (without legal compulsion) providing accurate and complete information, in connection with such
other party’s actual or contemplated defense, prosecution, or investigation of any claims or demands by or against third parties, or other matters, arising from events, acts, or failures to act that occurred during the period of
Executive’s employment by the Company. 
 [Signature Page Follows] 

  
 16 

 IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the date first written above. 
  

			
	ECPM HOLDINGS, LLC
		
	By:		  

			Name:
			Title:
	
	EXECUTIVE
	
	  
 David N.
Gill

  
 17EX-10.27

 Exhibit 10.27 
  

 
 EMPLOYMENT AGREEMENT 

Mr. Kevin Rubey 
 1199 Church Street 

Ventura, CA 93001 
 EndoChoice, Inc., a Delaware
corporation (together with its subsidiaries and affiliates, the “Company”), hereby enters into this Employment Agreement (the “Agreement”) with you, Kevin Rubey (“you” or
“Executive”), effective as of February 18, 2013 (the “Effective Date”). 
 The Company
and you agree as follows: 
 1. Position and Responsibilities. 

1.1 Position. You shall be employed by the Company in the capacity of Senior Vice President of Operations. In this capacity, you will
be responsible for, and shall also perform other duties and assignments consistent with, your responsibilities as Senior Vice President of Operations, as may be assigned to you from time to time by the Company’s COO. 

1.2 Location; Full-time Efforts. 

(a) In this capacity, the Company agrees that your job duties may be performed from the Company’s headquarters in the
metro Atlanta, Georgia area, or from your office in the Los Angeles/Ventura metro area, or other location mutually agreed upon by you and the Company. You shall also make yourself available for significant business travel, both within and outside
the United States of America, for purposes of managing the Company’s operations teams in Germany, Israel and China, and any other location, as well as consulting with customers, agents, representatives and suppliers of the Company and with
other members of the Company’s management. The Company acknowledges and agrees that your primary residence will be in the Los Angeles/Ventura, California metro area. 

(b) You will substantially devote your full working time and efforts to the performance of your job duties and the promotion of
the business and affairs of the Company. You may act as advisor or board member to other organizations with the prior approval of the Company’s CEO, and as long as such activities do not interfere with your Company job duties or performance.
The Company hereby acknowledges that you are: (i) Chairman of an Israeli medical device company, (ii) Chairman of a charitable foundation, and (iii) through December 31, 2013, on-call for phone consultation for your previous
employer, and agrees that you may continue such activities for as long as such activities do not interfere with your Company job duties or performance. 

1.3 Performance. You will perform your job duties and observe any and all reasonable rules and regulations that the Company may now
have or shall hereafter establish governing the conduct of its employees and business and provided to you in writing, including, without limitation the Company’s Employee Handbook and that certain Employment Covenants Agreement entered into
between you and the Company as of the date hereof (as may be amended or replaced from time to time, the “Employment Covenants Agreement”). 

 2. Compensation and Benefits. 

2.1 Base Salary. The Company shall pay to you for the services to be rendered hereunder a base salary at an annual rate of $235,000.00.
Such salary shall be payable in not less than monthly installments in accordance with the Company’s prevailing practice, as modified from time to time. 

2.2 Performance Bonus. You will be eligible to receive an annual bonus up to 30% of your base salary (a “Performance
Bonus”), based upon your professional performance (30%), as well as the performance of the Company (70%), as determined by the Board of Directors of the Company. 

2.3 Stock Incentive Plan. You will be eligible to participate in the ECPM Holdings, LLC Incentive Plan (the
“Plan”) as determined by the Board of Managers of ECPM Holdings, LLC (any grant under such Plan, an “Incentive Bonus”), all in accordance with, and subject to, the terms and conditions set forth in the
related incentive agreement between you and the ECPM Holdings, LLC (including, without limitation, a four-year vesting schedule). Subject to approval by the Board of Managers of ECPM Holdings, LLC, and the terms of the ECPM Holdings, LLC incentive
plan and incentive agreement (including a four-year vesting schedule), you will be granted 300,000 incentive units upon the Effective Date. 

2.4 Expenses. The Company shall reimburse you for all reasonable expenses (including travel expenses) incurred by you in the course of
performing your duties under this Agreement in accordance with any travel and expense reimbursement policy set forth by the Company’s President & CEO or Board of Directors. You will be entitled to fly ‘business class’ for any
air travel greater than six hours. The Company will provide cell phone service for conducting business of the Company as well as any other services required to perform your duties. 

2.5 Other Benefits. You will be entitled to receive such other benefits (including paid holidays and participation in pension, group
insurance and profit-sharing plans) as are made generally available by the Company to its other employees. 
 2.6 Vacation. You will
be entitled to four (4) weeks paid vacation in accordance with the Company’s vacation policy. As stated by current Company policy, you will not be paid for vacation that is not taken unless approved in writing in advance by the
Company’s President & CEO. 
 3. At-Will Employment; Notice Period. Your employment will be on an
“at-will” basis, which means that your employment with the Company is terminable any time for any reason with or without cause by either you or the company; provided, however, in the case of termination without cause, the terminating party
shall deliver to the other party a notice of at least 90 calendar days prior to termination. 
 4. Reasonableness of Terms; Continuing
Obligations.  
 (a) You hereby acknowledge and agree that you have received sufficient consideration and other benefits
hereunder and in connection with the transactions contemplated by this Agreement to clearly justify the restrictions contained in this Agreement and the Employment Covenants Agreement. You have carefully considered the nature and extent of the
restrictions placed upon you by Employment Covenants Agreement, and hereby acknowledge and agree that such restrictions are reasonable in time 

  
 2 

 
and territory and do not confer a benefit upon the Company disproportionate to your detriment. You acknowledge that the covenants set forth in the Employment Covenants Agreement are a condition
precedent to the execution of this Agreement and the consummation of the transactions contemplated hereby by the Company. In addition, the parties hereto acknowledge and agree that the covenants contained in the Employment Covenants Agreement are an
integral part of the transactions contemplated by this Agreement and are a material inducement for the Company to enter into this Agreement and to perform its respective obligations hereunder. The parties recognize and acknowledge that a breach by
you of this Agreement or the Employment Covenants Agreement will cause irreparable and material loss and damage to the Company, the amount of which cannot be readily determined and as to which it will not have an adequate remedy at law or in
damages. It is the desire and intent of the parties that the provisions of the Employment Covenants Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is
sought. 
 (b) Your duties under the Employment Covenants Agreement survive termination of your employment with the Company. 

6. Former Employment. You represent and warrant that your employment with the Company will not be in violation of any term of
any employment contract, consulting arrangement, patent disclosure agreement, non-competition agreement or any other contract or agreement with any prior employer or any other person or entity or any obligation imposed by common law or otherwise,
relating to your right to be employed by the Company. You represent and warrant that you do not possess confidential information arising out of prior employment (other than with the Company), which, in your best judgment, would be utilized in
connection with your employment by the Company. 
 7. Remedies. Each of the obligations shall be enforceable independently of
every other obligation, and the existence of any claim or cause of action that you may have against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of these
obligations. You understand and acknowledge that the provisions of this Agreement and the Employment Covenants Agreement are necessary to protect the legitimate business interests of the Company and are fair and reasonable. You acknowledge that any
breach by yourself of any of the provisions of this Agreement will result in irreparable and continuing damage to the Company and that a remedy at law for any breach or threatened breach by yourself of the provisions of this Agreement would be
inadequate, and you therefore agree that the Company shall be entitled to seek temporary, preliminary and permanent injunctive relief without the need for the Company to post a bond or the necessity of proving damages, in case of any such breach or
threatened breach. Nothing in this Agreement shall be construed to prohibit the Company from pursuing any other remedy available to it at law or in equity, the parties having agreed that all remedies are cumulative. 

8. Miscellaneous. 

8.1 Assignment. This Agreement and the rights and obligations of the parties hereto shall bind and inure to the benefit of any
successor or successors of the Company by reorganization, merger or consolidation and any assignee of all or substantially all of its business and properties to which this Agreement is also assigned by the Company. Except as set forth in this
Section 8.1, neither this Agreement nor any rights or benefits hereunder may be assigned by the Company or you. 
 8.2 Notices.
All notices, consents, waivers and other communications under this Agreement must be in writing and will be deemed to have been duly given when (a) delivered by hand (with written confirmation of receipt), (b) sent by facsimile (with
written confirmation of receipt), provided that a copy 

  
 3 

 
is mailed by registered mail, return receipt request or (c) when received by the addressee, if sent by a nationally recognized overnight delivery service (receipt requested), in each case to
the appropriate addresses and facsimile numbers set forth below (or to such other addresses and facsimile numbers as a party may designate by notice to the other parties): 
  

			
	If to the Company:		EndoChoice, Inc.
			11810 Wills Road
			Alpharetta, GA 30009
			Facsimile: 770-962-6981
			Attn: Office of General Counsel

  

			
	If to you:		Mr. Kevin Rubey
			1199 Church Street
			Ventura, CA 93001

 8.3 Severability, Enforcement and Jurisdiction. If any provision of this Agreement or the Employment
Covenants Agreement is unlawful or against public policy and thus void or is otherwise declared void, such provision will not be deemed a part of this Agreement and the remaining sections of this Agreement will be unaltered and fully enforceable. If
a court decides that any part of this Agreement is unfair under the circumstances existing at the time of its review, such court shall enforce the restrictions of this Agreement to provide us with the maximum protection that the court decides is
reasonable. 
 8.4 Waivers. No term or condition of this Agreement shall be deemed to have been waived, nor shall there be any
estoppel against the enforcement of any provision of this Agreement, except by written instrument of the party charged with such waiver or estoppel. No such written waiver shall be deemed a continuing waiver unless specifically stated therein, and
each such waiver shall operate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived. If either party shall waive any breach
of any provision of this Agreement, she/he or it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. 

8.5 Counterparts. This Agreement may be executed in counterparts, each of which when so executed and delivered shall constitute a
complete and original instrument but all of which together shall constitute one and the same agreement, and it shall not be necessary when making proof of this Agreement or any counterpart thereof to account for any other counterpart. 

8.6 Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of
Georgia, without regard to principles of conflict of laws. 
 8.7 Complete Agreement; Amendments, Prior Agreements. This Agreement,
together with the Employment Covenants Agreement, constitutes the entire agreement of the parties with respect to the subject matter hereof and may not be amended, supplemented, canceled or discharged except by written instrument executed by both
parties hereto. This Agreement supersedes any and all prior agreements between the Company and you with respect to the matters covered hereby. 

8.8 Headings, Etc. The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be
deemed to be a part of this Agreement. 

  
 4 

 9. Compliance with Section 409A. 

9.1 General Code Section 409A Provisions. It is intended that the terms of this Agreement, including any ambiguous terms, be
interpreted in a manner consistent with Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”). It is also intended that, for all purposes, “termination of employment” (or similar terms) as
used herein shall mean “separation from service” (within the meaning provided by Treasury Regulation Section 1.409A-1(h)) in accordance with Treasury Regulation Section 1.409A-3(a)(1). Any
provision that would cause this Agreement or any payment hereunder, to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by
Section 409A. The direct payment or reimbursement of expenses permitted under this Agreement or otherwise shall be made no later than the last day of your taxable year following the taxable year in which such expense was incurred.
Notwithstanding anything herein to the contrary, in no event shall the Company be liable to you for, or with respect to, any taxes, penalties, or interest which may be imposed upon you pursuant to Section 409A. For purposes of compliance with
Code Section 409A, Executive’s right to receive any installment payments pursuant to this Agreement shall be treated as right to receive a series of separate and distinct payment. Whenever a payment under this Agreement specifies a payment
period with reference to a number of days, the actual date within the specified period shall be within the sole discretion of the Company. 

9.2 Six-Month Delay. If it is determined that (a) you are a “specified employee,” as defined in
Section 409A(a)(2)(B)(i) and the regulations and other guidance promulgated thereunder, and any elections made by you in accordance therewith, and (b) such payments constitute a distribution of deferred compensation (within the meaning of
Treasury Regulation Section 1.409A-1(b)) upon separation from service (within the meaning of Treasury Regulation Section 1.409A-1(h)), after taking into account all available exemptions, then notwithstanding the timing of payment provided
in any other Section of this Agreement, no payment, distribution, or benefit under this Agreement that constitutes a distribution of deferred compensation and that would otherwise be payable during the six (6) month period after your
termination of employment, will be made during such six (6) month period, and any such payment, distribution or benefit will instead be paid on the first business day after such six (6) month period. 

9.3 Payments and Benefits. To the extent that severance payments or benefits pursuant to this Agreement are conditioned upon the
execution and delivery by Executive of a release of claims, the Company shall provide the release of claims upon a termination of employment and Executive shall forfeit all rights to such payments and benefits unless such release is signed and
delivered within twenty-one (21) calendar days following the date of Executive’s termination of employment. A seven (7) day revocation period after the release agreement is signed and returned will apply. If the foregoing release is
executed and delivered and no longer subject to revocation as provided in the preceding sentence, then the following shall apply: 
 (a) To
the extent that any such cash payment or continuing benefit to be provided is not “nonqualified deferred compensation” for purposes of Code Section 409A, then such payment or benefit shall commence upon the first scheduled payment
date immediately following the date that the release is executed, delivered and no longer subject to revocation (the “Release Effective Date”). The first such cash payment shall include payment of all amounts that otherwise would
have been due prior to the Release Effective Date under the terms of this Agreement applied as though such payments commenced immediately upon Executive’s termination of employment, and any payments made thereafter shall continue as provided
herein. The delayed benefits shall in any event expire at the time such benefits would have expired had such benefits commenced immediately following Executive’s termination of employment. 

  
 5 

 (b) To the extent that any such cash payment or continuing benefit to be provided is
“nonqualified deferred compensation” for purposes of Code Section 409A, then such payments or benefits shall be made or commence on the first payroll following the twenty first (21st) day following Executive’s termination of
employment. The first such cash payment shall include payment of all amounts that otherwise would have been due prior thereto under the terms of this Agreement had such payments commenced immediately upon Executive’s termination of employment,
and any payments made thereafter shall continue as provided herein. The delayed benefits shall in any event expire at the time such benefits would have expired had such benefits commenced immediately following Executive’s termination of
employment. 
 (c) For purposes of compliance with Code Section 409A, (i) all expenses or other reimbursements hereunder shall be
made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by Executive, (ii) any right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another
benefit, and (iii) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other
taxable year. 

  
 6 

 IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the Effective Date.

  

			
	ENDOCHOICE, INC.
		
	By:		 /s/

	Name:		Mark Gilreath
	Title:		President & CEO

  

			
	Accepted and agreed:
	
	 /s/

	Name: Kevin Rubey
		
	Dated:		 February 18, 2013

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]